Abu-Sbeih H - Search Results

1

Clinical Review on the Utility of Fecal Microbiota Transplantation in Immunocompromised Patients.

Abu-Sbeih H, Ali FS, Wang Y. Abu-Sbeih H, et al. Curr Gastroenterol Rep. 2019 Feb 28;21(4):8. doi: 10.1007/s11894-019-0677-6. Curr Gastroenterol Rep. 2019. PMID: 30815766 Review.

2

Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease.

Abu-Sbeih H, Wang Y. Abu-Sbeih H, et al. Inflamm Bowel Dis. 2020 Apr 11;26(5):662-668. doi: 10.1093/ibd/izz212. Inflamm Bowel Dis. 2020. PMID: 31560045 Review.

3

Immune-checkpoint inhibitors induced diarrhea and colitis: a review of incidence, pathogenesis and management.

Abu-Sbeih H, Ali FS, Wang Y. Abu-Sbeih H, et al. Curr Opin Gastroenterol. 2020 Jan;36(1):25-32. doi: 10.1097/MOG.0000000000000593. Curr Opin Gastroenterol. 2020. PMID: 31609734 Review.

4

Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson.

Wang Y, Abu-Sbeih H, Mao E, Ali N, Ali FS, Qiao W, Lum P, Raju G, Shuttlesworth G, Stroehlein J, Diab A. Wang Y, et al. J Immunother Cancer. 2018 May 11;6(1):37. doi: 10.1186/s40425-018-0346-6. J Immunother Cancer. 2018. PMID: 29747688 Free PMC article. Review.

5

Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis.

Abu-Sbeih H, Ali FS, Luo W, Qiao W, Raju GS, Wang Y. Abu-Sbeih H, et al. J Immunother Cancer. 2018 Sep 25;6(1):95. doi: 10.1186/s40425-018-0411-1. J Immunother Cancer. 2018. PMID: 30253811 Free PMC article.

6

Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients.

Abu-Sbeih H, Choi K, Tran CN, Wang X, Lum P, Shuttlesworth G, Stroehlein JR, Okhuysen PC, Wang Y. Abu-Sbeih H, et al. Eur J Gastroenterol Hepatol. 2019 Jan;31(1):128-134. doi: 10.1097/MEG.0000000000001288. Eur J Gastroenterol Hepatol. 2019. PMID: 30339561

7

Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.

Wang Y, Wiesnoski DH, Helmink BA, Gopalakrishnan V, Choi K, DuPont HL, Jiang ZD, Abu-Sbeih H, Sanchez CA, Chang CC, Parra ER, Francisco-Cruz A, Raju GS, Stroehlein JR, Campbell MT, Gao J, Subudhi SK, Maru DM, Blando JM, Lazar AJ, Allison JP, Sharma P, Tetzlaff MT, Wargo JA, Jenq RR. Wang Y, et al. Nat Med. 2018 Dec;24(12):1804-1808. doi: 10.1038/s41591-018-0238-9. Epub 2018 Nov 12. Nat Med. 2018. PMID: 30420754 Free PMC article.

8

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study.

Abu-Sbeih H, Ali FS, Alsaadi D, Jennings J, Luo W, Gong Z, Richards DM, Charabaty A, Wang Y. Abu-Sbeih H, et al. J Immunother Cancer. 2018 Dec 5;6(1):142. doi: 10.1186/s40425-018-0461-4. J Immunother Cancer. 2018. PMID: 30518410 Free PMC article.

9

Safety of endoscopy in cancer patients with thrombocytopenia and neutropenia.

Abu-Sbeih H, Ali FS, Coronel E, Chen HC, Wang X, Lum P, Shuttlesworth G, Bhutani MS, Raju GS, Lee JH, Stroehlein JR, Ross WA, Wang Y. Abu-Sbeih H, et al. Gastrointest Endosc. 2019 May;89(5):937-949.e2. doi: 10.1016/j.gie.2018.12.004. Epub 2018 Dec 11. Gastrointest Endosc. 2019. PMID: 30550744

10

Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma.

Abu-Sbeih H, Ali FS, Qiao W, Lu Y, Patel S, Diab A, Wang Y. Abu-Sbeih H, et al. Cancer Immunol Immunother. 2019 Apr;68(4):553-561. doi: 10.1007/s00262-019-02303-1. Epub 2019 Jan 21. Cancer Immunol Immunother. 2019. PMID: 30666357 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters